PedAM
Pediatric Disease Annotations & Medicines
| Disease | arteriosclerosis |
| Phenotype | C0024141|systemic lupus erythematosus |
| Sentences | 41 |
| PubMedID- 23060481 | We hypothesized that increased inflammation is associated with increased ffas, resulting in insulin resistance and atherosclerosis in patients with systemic lupus erythematosus (sle). |
| PubMedID- 20132070 | Objectives: to study the link between metabolic syndrome (mets), endothelial injury, and atherosclerosis in patients with systemic lupus erythematosus (sle). |
| PubMedID- 20044088 | Background: systemic lupus erythematosus (sle) is associated with premature atherosclerosis but the mechanisms underlying this association are not understood. |
| PubMedID- 22196362 | Anti-phospholipid antibodies contribute to arteriosclerosis in patients with systemic lupus erythematosus through induction of tissue factor expression and cytokine production from peripheral blood mononuclear cells. |
| PubMedID- 23620348 | Progression of carotid atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 23082493 | Mannose binding lectin gene polymorphism and preclinical carotid atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 23526148 | Th17/treg imbalance induced by increased incidence of atherosclerosis in patients with systemic lupus erythematosus (sle). |
| PubMedID- 23792700 | atherosclerosis in systemic lupus erythematosus. |
| PubMedID- 24699314 | Genetic variation and coronary atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 26455562 | Subclinical atherosclerosis in patients with systemic lupus erythematosus: a systemic review and meta-analysis. |
| PubMedID- 22910888 | In addition, very recently, mcmahon and colleagues have demonstrated that leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus and that there is no significant association between adiponectin and atherosclerotic plaques in sle [132]. |
| PubMedID- 24711757 | Hcq might have improved vascular function in our study population, since it has been shown to exert a mild protective effect against atherosclerosis in patients with systemic lupus erythematosus (45). |
| PubMedID- 19955049 | Premature aortic atherosclerosis in systemic lupus erythematosus: a controlled transesophageal echocardiographic study. |
| PubMedID- 26183767 | Cd4+cxcr3+ t cells and plasmacytoid dendritic cells drive accelerated atherosclerosis associated with systemic lupus erythematosus. |
| PubMedID- 24790989 | atherosclerosis is accelerated in patients with systemic lupus erythematosus (sle) and it leads to excessive cardiovascular complications in these patients. |
| PubMedID- 25638414 | Striking phenomena of atherosclerosis associated with systemic lupus erythematosus (sle) is its high incidence in young patients. |
| PubMedID- 20014976 | atherosclerosis in systemic lupus erythematosus. |
| PubMedID- 20890983 | Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. |
| PubMedID- 24478772 | However, high levels of stweak were associated with atherosclerosis in patients with systemic lupus erythematosus (sle), but not in control subjects (87). |
| PubMedID- 20682673 | Nuclear magnetic resonance lipoprotein subclasses and the apoe genotype influence carotid atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 21110795 | Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus: comments on the article by mok et al. |
| PubMedID- 26251402 | Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 22113625 | Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches. |
| PubMedID- 21426260 | Current approaches to the prevention of atherosclerosis in systemic lupus erythematosus involve targeting modifiable cardiac risk factors. |
| PubMedID- 23084817 | Efficacy and safety of statins in the prevention of atherosclerosis in patients with systemic lupus erythematosus--a meta-analysis of randomized controlled trials. |
| PubMedID- 24261762 | Pentraxin 3 is associated with disease activity but not atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 21670088 | High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids. |
| PubMedID- 21280004 | Objective: an increased risk of premature atherosclerosis has been associated with systemic lupus erythematosus (sle), and type i interferon (ifn) has been shown to play a pathogenic role in human sle. |
| PubMedID- 22709931 | The detection of autoantibodies to atp-binding cassette transporter a1 and its role in the pathogenesis of atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 25593786 | Aortic atherosclerosis in systemic lupus erythematosus. |
| PubMedID- 19687018 | Factors involved in the progress of preclinical atherosclerosis associated with systemic lupus erythematosus: a 2-year longitudinal study. |
| PubMedID- 24021339 | Objectives: although a series of trials support systemic lupus erythematosus (sle) is associated with increased atherosclerosis and cardiovascular events, the link between microvascular structural change and the disease activity of sle is not defined. |
| PubMedID- 20007814 | We tested the hypothesis that carotid atherosclerosis in systemic lupus erythematosus (sle) is associated with poor health-related quality of life (hrqol), which is independent of any association with traditional risk factors (trfs), lifestyle and socioeconomic factors. |
| PubMedID- 21979131 | The problem of accelerated atherosclerosis in systemic lupus erythematosus: insights into a complex co-morbidity. |
| PubMedID- 22194660 | In addition, very recently, mcmahon and colleagues have demonstrated that leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus and that there is no significant association between adiponectin and atherosclerotic plaques in sle [24]. |
| PubMedID- 23945845 | Aim: accelerated atherosclerosis in systemic lupus erythematosus (sle) is an important cause of morbidity and mortality. |
| PubMedID- 20813797 | To assess aortic stiffness by transesophageal echocardiography (tee) and to determine its clinical predictors and relation to age, blood pressure, renal function, and atherosclerosis, 50 patients with systemic lupus erythematosus (sle), 94% women, with a mean age of 38 +/- 12 years, and 22 age and gender-matched healthy controls underwent clinical and laboratory evaluations and multiplane tee to assess stiffness, intima-media thickness (imt), and plaques of the proximal, mid, and distal descending thoracic aorta. |
| PubMedID- 26299985 | The conclusion of this review has covered accelerated atherosclerosis in systemic lupus erythematosus, the role of complement, interferon in premature atherosclerosis, inflammatory mediators such as cytokines, leukocytes, innate and adaptive immunity, hydrolytic enzymes, reactive oxygen species, vascular endothelial growth factor, toll receptors in lupus nephritis, several specific anti-inflammatory pharmacological therapies, and potential prevention strategies for atherothrombotic events, interferons and the inflammasome. |
| PubMedID- 24376005 | Risk factors in the progression of subclinical atherosclerosis in women with systemic lupus erythematosus. |
| PubMedID- 25159099 | We sought to investigate the relationship between bmd and vf and carotid atherosclerosis in women with systemic lupus erythematosus (sle). |
| PubMedID- 20936125 | Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches. |
Page: 1